In addition, the frequency of positivity for BCL-6 mRNA in plasma was higher in DLBCL than in FL patients (p=0.005, χ2 test), and presence of BCL-XL was lower in DLBCL (p=0.024, χ2 test). The gene discussed is BCL2L1; the disease is diffuse large B-cell lymphoma.